期刊文献+

脉血康胶囊对凝血功能的影响 被引量:9

下载PDF
导出
摘要 目的观察脉血康胶囊对凝血功能的影响。方法48例高血凝状态患者予脉血康口服,测定治疗前后血浆凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)及纤维蛋白原(FIB)的变化。结果治疗后INP由(1.27±0.14)s延长至(1.41±0.25)s,APTT由(34.67±5.65)s延长至(39.23±6.27)s,TT由(15.19±1.23)s延长至(16.35±2.17)s,均较治疗前明显延长;FIB治疗前(2.88±0.75)g/L,治疗后2.66±0.75g/L,无显著变化。结论脉血康胶囊作为水蛭制剂,具有改善高血凝状态的作用。
出处 《中国中医急症》 2007年第4期479-480,共2页 Journal of Emergency in Traditional Chinese Medicine
  • 相关文献

参考文献3

二级参考文献26

  • 1法祥光 甘午君 等.红细胞膜流动性的测定及其初步应用[J].中华血液学杂志,1984,5(2):132-132.
  • 2石琳 秦正红 等.用荧光偏振技术研究3,4-二羟基苯乙酮对血小板膜流动性影响[J].中国药理学报,1986,7(2):42-42.
  • 3[1]Weitz JI,Buller HR.Direct thrombin inhibitors in acute coronary syndromes.Circulation,2002,105:1004-1011.
  • 4[2]Sarich TC,Wolzt M,Eriksson UG,et al.Effects of ximelagatran,an oral direct thrombin inhibitor,r-hirudin and enoxaparin on thrombin generation and platelet activation in healthy male subjects.J Am Coll Cardio,2003,41:557-564.
  • 5[3]The Direct Thrombin Inhibitor Trialists' Collaborative Group.Direct thrombin inhibitors in acute coronary syndromes:principal results of a meta-analysis based on individual patients' data.Lancet,2002,359:294-302.
  • 6[4]Organisation to Assess Strategies for Ischemic Syndromes (OASIS) Investigators.Comparison of the effects of two doses of recombinant hirudin compared with heparin in patients with acute myocardial ischemia without ST elevation:a pilot study.Circulation,1997,96:769-777.
  • 7[5]Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators.Effects of recombinant hirudin (lepirudin) compared with heparin on death,myocardial infarction,refractory angina,and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation:a randomised trial.Lancet,1999,353:429-438.
  • 8[6]The Global Use of Strategies to Open Occluded Arteries (GUSTO) Ⅱb Investigators.A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes.N Engl J Med,1996,335:775-782.
  • 9[7]White H.The hirulog and early reperfusion or occlusion (HERO)-2 trial investigators.Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction:the HERO-2 randomised trial.Lancet,2001,348:1855-1863.
  • 10[8]Mehta SR,Eikelboom JW,Rupprecht H J,et al.Efficacy of hirudin in reducing cardiovascular events in patients with acute coronary syndrome undergoing early percutaneous coronary intervention.Eur Heart J,2002,23:117-123.

共引文献85

同被引文献53

引证文献9

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部